Junghwa Do
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Junghwa Do has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Jae Yong Jeon
Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
2 shared publications A. Hyun Kim
Rehabilitation Medicine Team Asan Medical Center, University of Ulsan College of Medicine Seoul Republic of Korea
1 shared publicationDpt
1 shared publicationHwayeong Cheon
Rehabilitation Research Center, Biomedical Engineering Research Center Asan Medical Center Seoul Republic of Korea
1 shared publication- JaYoung Kim
Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
1 shared publication Md
1 shared publication
Latest Publications
- Open Access
- 26 August 2026
- Published by Wiley in Thoracic Cancer
- Vol. 17 (17) , e70349
Validity and Feasibility of the Constant‐Load Cycle Endurance Test in Lung Cancer Patients Undergoing Radiation Therapy
Purpose: This study evaluated the validity of the constant‐load cycle endurance test (CET), performed at 75% of maximal power output, in patients with lung cancer undergoing radiation therapy. Its feasibility, responsiveness to pulmonary rehabilitation (PR), and clinical applicability were also examined. Methods: Thirty‐three patients participated in a 4‐week PR program during radiation therapy. CET time was compared with the 6‐min walk test (6MWT) to assess concurrent validity. Patients were stratified by 6MWT distance (≥ 450 m = active; < 450 m = inactive). CET, 6MWT, knee extensor strength, and handgrip strength were measured at baseline and post‐PR. Adverse events were monitored. Results: CET time showed a moderate correlation with 6MWT distance ( r = 0.57, p < 0.001). The correlation was stronger in the active subgroup ( r = 0.61, p < 0.001) but not significant in the inactive subgroup ( r = 0.09, p = 0.63). After PR, significant improvements were observed in CET, knee extensor (left) strength ( p < 0.05). Subgroup analysis indicated that inactive patients primarily improved in 6MWT, whereas active patients showed greater gains in CET. No adverse events occurred during testing or PR. Conclusions: CET demonstrated moderate validity with the 6MWT and was responsive to PR, particularly in patients with higher functional capacity. CET appears feasible, safe, and complementary to walk tests, potentially capturing improvements masked by ceiling effects. Larger studies are needed to confirm its role as a standard outcome measure in PR for lung cancer.
- 26 August 2026
- Published by Wiley in Thoracic Cancer
- Vol. 17 (17) , e70349
Open AccessValidity and Feasibility of the Constant‐Load Cycle Endurance Test in Lung Cancer Patients Undergoing Radiation Therapy
Purpose: This study evaluated the validity of the constant‐load cycle endurance test (CET), performed at 75% of maximal power output, in patients with lung cancer undergoing radiation therapy. Its feasibility, responsiveness to pulmonary rehabilitation (PR), and clinical applicability were also examined. Methods: Thirty‐three patients participated in a 4‐week PR program during radiation therapy. CET time was compared with the 6‐min walk test (6MWT) to assess concurrent validity. Patients were stratified by 6MWT distance (≥ 450 m = active; < 450 m = inactive). CET, 6MWT, knee extensor strength, and handgrip strength were measured at baseline and post‐PR. Adverse events were monitored. Results: CET time showed a moderate correlation with 6MWT distance ( r = 0.57, p < 0.001). The correlation was stronger in the active subgroup ( r = 0.61, p < 0.001) but not significant in the inactive subgroup ( r = 0.09, p = 0.63). After PR, significant improvements were observed in CET, knee extensor (left) strength ( p < 0.05). Subgroup analysis indicated that inactive patients primarily improved in 6MWT, whereas active patients showed greater gains in CET. No adverse events occurred during testing or PR. Conclusions: CET demonstrated moderate validity with the 6MWT and was responsive to PR, particularly in patients with higher functional capacity. CET appears feasible, safe, and complementary to walk tests, potentially capturing improvements masked by ceiling effects. Larger studies are needed to confirm its role as a standard outcome measure in PR for lung cancer.
- Open Access
- 20 August 2020
- Published by Korean Research Society of Physical Therapy in Physical Therapy Korea
- Vol. 27 (3) , 220-226
Physical Therapy for Esophageal Cancer Patient With Long Thoracic Neuropathy After Esophagectomy: A Case Report
Junghwa Do, PhD, DPT, One-bin Lim, PhD, PT, Ja-young Kim, MD, Jae Yong Jeon, PhD, MD, Young-ki Cho, PhD, PT. Phys. Ther. Korea 2020;27:220-6. https://doi.org/10.12674/ptk.2020.27.3.220
- 20 August 2020
- Published by Korean Research Society of Physical Therapy in Physical Therapy Korea
- Vol. 27 (3) , 220-226
Open AccessPhysical Therapy for Esophageal Cancer Patient With Long Thoracic Neuropathy After Esophagectomy: A Case Report
Junghwa Do, PhD, DPT, One-bin Lim, PhD, PT, Ja-young Kim, MD, Jae Yong Jeon, PhD, MD, Young-ki Cho, PhD, PT. Phys. Ther. Korea 2020;27:220-6. https://doi.org/10.12674/ptk.2020.27.3.220